Elucidation of muscle-binding peptides by phage display screening

Muscle and Nerve

Volumn 22, Issue 4, 1999, Pages 460-466

  Samoylova, Tatiana I ^a   Smith, Bruce F ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Ligand; Muscle; Peptide; Phage display; Skeletal Bruce F. Smith

Indexed keywords

MUSCLE PROTEIN; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ANIMALS; BACTERIOPHAGES; CELL LINE; IMMUNOHISTOCHEMISTRY; MICE; MUSCLES; PEPTIDE LIBRARY; PROTEIN BINDING;

EID: 0032912835     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199904)22:4<460::AID-MUS6>3.0.CO;2-L     Document Type: Article

References (37)

1. Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA, Davies KE. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 1991;352:815-818.
2. Acsadi G, Lochmüller H, Jani A, Huard J. Massie B, Prescoll S, Simoneau M, Petrof BJ, Karpati G. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther 1996;7:129-140.
3. Arap W, Pasqualini R, Ruoslahti K. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998;279:377-380.
4. Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nature Med 1996;2:299-305.
5. Blau HM, Springer ML. Muscle-mediated gene therapy. N Engl J Med 1995;333:1554-1556.
6. Clark KR, Sferra TJ, Johnson PR. Recombinant adeno-associated viral vectors mediate long-term transgenc expression in muscle. Hum Gene Ther 1997;8:659-669.
7. Clemens PR, Kochanek S, Sunada Y, Chan S, Chen HH, Campbell KP, Caskey CT. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther 1996;3:965-972.
8. Cortese R, Monaci P, Luzzago A, Santini C, Bartoli F, Cortese I, Fortugno P, Galfre G, Nicosia A, Felici F. Selection of biologically active peptides by phage display of random peptide libraries. Curr Opin Biotech 1996;7:616-621.
9. Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N, Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995;92:1401-1405.
10. Daniels DA, Lane DP. Phage peptide libraries. Methods 1996; 9:494-507.
11. Davis HL, Whalen RG, Demeneix BA. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum Gene Ther 1993;4: 151-159.
12. Dickson G: Gene transfer to muscle. Biochem Soc Trans 1996; 24:514-519.
13. Dunckley MG, Wells DJ, Walsh FS, Dickson G. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum Mol Genet 1993;2:717-723.
14. Dwarki VJ, Belloni P, Nijjar T, Smith J, Couto L, Rabier M, Clift S, Berns A, Cohen LK. Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. Proc Natl Arad Sci USA 1995;92:1023-1027.
15. Fisher KJ, Jooss K, Alston J, Yang Y. Haecker SE, High K, Pathak R, Raper SE, Wilson JM. Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med 1997;3:306-312.
16. Haecker SE, Stedman HH, Balice-Gordon RJ, Smith DBJ. Greelish JP, Mitchell MA, Wells A, Sweeney HL, Wilson JM. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther 1996; 7:1907-1914.
17. Hartikka J, Sawdey M, Cornefert-Jensen F, Margalith M, Barnhart K, Nolasco M, Vahlsing HL, Meek J,. Marquet M, Hobart P, Norman J, Manthorpe M. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 1996;7:1205-1217.
18. Huard J, Lochmüller H, Acsadi G, Jani A, Massie B, Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 1995;2:107-115.
19. Ito M, Kedes L. Two-step delivery of retroviruscs to postmitotic, terminally differentiated cells. Hum Gene Ther 1997; 8:57-63.
20. Katz BA. Structural and mechanistic determinants of affinity and specificity of ligands discovered or engineered by phage display. Annu Rev Biophys Biomol Struct 1997;26:27-45.
21. Kinoshita I, Vilquin JT, Tremblay JP. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice. Acta Neuropathol (Berl) 1996;91:489-493.
22. Li K, Welikson RE, Vikstrom KL, Leinwand LA. Direct gene transfer into the mouse heart. J Mol Cell Cardiol 1997;29: 1499-1504.
23. Lowman HB. Bacteriophage display and discovery of peptide leads for drug development. Annu Rev Biophys Biomol Struct 1997;26:401-424.
24. Marks JD, Ouwehand WH, Bye JM, Finnern R, Gorick BD, Voak D, Thorpe SJ, Hughes-Jones NC, Winter G. Human antibody fragments specific for human blood group antigens from a phage display library. Bio/Technology 1993;11: 1145-1148.
25. McGregor D. Selection of proteins and peptides from libraries displayed on filamentous bacteriophage. Mol Biotechnol 1996;6:155-162.
26. Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, Nagaraja H, Stephens R, Lantry L, Morris GE, Burghes AHM. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. New Engl J Med 1995;333:832-838.
27. Miller AD. Putting muscle to work for gene therapy. Nature Med 1997;3:278-279.
28. Pasqualini R, Koivunen E, Ruoslahti E. αv-Integrins as receptors for tumor targeting by circulating ligands. Nature Biotech 1997;15:542-546.
29. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996;380:364-366.
30. Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan J, Perricaudet M, Kahn A. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 1993; 361:647-650.
31. Siegel DL, Silberstein LE. Expression and characterization of recombinant anti-Rh(D) antibodies on filamentous phage: a model system for isolating human red blood cell antibodies by repertoire cloning. Blood 1994;83:2334-2344.
32. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985;228:1313-1317.
33. Smith GP, Petrenko VA. Phage display. Chem Rev 1997;97: 391-410.
34. Smith GP, Scott JK. Libraries of peptides and proteins displayed on filamentous phage. In: Wu R, editor. Methods in enzymology. New York: Academic Press; 1993. p 228-257.
35. Svensson EG, Tripathy SK, Leiden JM. Muscle-based gene therapy: realistic possibilities for the future. Mol Med Today 1996;2:166-172.
36. Wang JM, Zheng H, Sugahara Y, Tan J, Yao SN, Olson E, Kurachi K. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells. Hum Gene Ther 1996;7:1743-1756.
37. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL. Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-1468.